Medy-Tox Statistics

Total Valuation

Medy-Tox has a market cap or net worth of KRW 892.21 billion. The enterprise value is 912.46 billion.

Market Cap	892.21B
Enterprise Value	912.46B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Medy-Tox has 7.02 million shares outstanding. The number of shares has decreased by -3.59% in one year.

Current Share Class	7.02M
Shares Outstanding	7.02M
Shares Change (YoY)	-3.59%
Shares Change (QoQ)	+9.37%
Owned by Insiders (%)	19.28%
Owned by Institutions (%)	11.41%
Float	5.23M

Valuation Ratios

The trailing PE ratio is 37.40 and the forward PE ratio is 37.28.

PE Ratio	37.40
Forward PE	37.28
PS Ratio	3.69
PB Ratio	1.91
P/TBV Ratio	1.98
P/FCF Ratio	16.62
P/OCF Ratio	14.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.82, with an EV/FCF ratio of 17.00.

EV / Earnings	41.78
EV / Sales	3.77
EV / EBITDA	18.82
EV / EBIT	32.23
EV / FCF	17.00

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.16.

Current Ratio	1.79
Quick Ratio	1.22
Debt / Equity	0.16
Debt / EBITDA	1.83
Debt / FCF	1.42
Interest Coverage	12.53

Financial Efficiency

Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 2.41%.

Return on Equity (ROE)	4.38%
Return on Assets (ROA)	2.23%
Return on Invested Capital (ROIC)	2.41%
Return on Capital Employed (ROCE)	4.40%
Revenue Per Employee	336.76M
Profits Per Employee	30.42M
Employee Count	718
Asset Turnover	0.40
Inventory Turnover	1.84

Taxes

In the past 12 months, Medy-Tox has paid 112.04 million in taxes.

Income Tax	112.04M
Effective Tax Rate	0.53%

Stock Price Statistics

The stock price has increased by +2.50% in the last 52 weeks. The beta is 0.16, so Medy-Tox's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+2.50%
50-Day Moving Average	122,104.00
200-Day Moving Average	140,605.00
Relative Strength Index (RSI)	58.24
Average Volume (20 Days)	33,058

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medy-Tox had revenue of KRW 241.80 billion and earned 21.84 billion in profits. Earnings per share was 3,398.79.

Revenue	241.80B
Gross Profit	139.81B
Operating Income	21.64B
Pretax Income	21.26B
Net Income	21.84B
EBITDA	41.82B
EBIT	21.64B
Earnings Per Share (EPS)	3,398.79

Full Income Statement

Balance Sheet

The company has 59.33 billion in cash and 76.39 billion in debt, giving a net cash position of -17.06 billion or -2,429.94 per share.

Cash & Cash Equivalents	59.33B
Total Debt	76.39B
Net Cash	-17.06B
Net Cash Per Share	-2,429.94
Equity (Book Value)	467.65B
Book Value Per Share	66,216.60
Working Capital	75.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 61.30 billion and capital expenditures -7.63 billion, giving a free cash flow of 53.67 billion.

Operating Cash Flow	61.30B
Capital Expenditures	-7.63B
Free Cash Flow	53.67B
FCF Per Share	7,645.24

Full Cash Flow Statement

Margins

Gross margin is 57.82%, with operating and profit margins of 8.95% and 9.44%.

Gross Margin	57.82%
Operating Margin	8.95%
Pretax Margin	8.79%
Profit Margin	9.44%
EBITDA Margin	17.29%
EBIT Margin	8.95%
FCF Margin	22.20%

Dividends & Yields

This stock pays an annual dividend of 1,200.00, which amounts to a dividend yield of 0.95%.

Dividend Per Share	1,200.00
Dividend Yield	0.95%
Dividend Growth (YoY)	9.09%
Years of Dividend Growth	n/a
Payout Ratio	36.92%
Buyback Yield	3.59%
Shareholder Yield	4.54%
Earnings Yield	2.45%
FCF Yield	6.02%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.05

Scores

Medy-Tox has an Altman Z-Score of 6.68 and a Piotroski F-Score of 6.

Altman Z-Score	6.68
Piotroski F-Score	6